Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Acetic Acid | HCID 176 | — |
| Reactant | 1-Hydroxybenzotriazole | HCID 75771 | — |
| Reactant | (Z)-2-(2-Tritylaminothiazol-4-yl)-2-methoxyiminoacetic acid | HCID 2724510 | — |
| Reactant | HCID 13960529 | HCID 13960529 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | HCID 54463668 | HCID 54463668 | 56.3% |
Reaction Steps
The syn isomer of 2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetic acid (5.32 g), 3-hydroxybenzotriazole (1.62 g) and N,N-dicyclohexylcarbodiimide (2.47 g) are added to a solution, cooled to +5° C., of 7-amino-2-benzhydryloxycarbonyl-8-oxo-3-[2-(pyridin-3-yl-methyl)-thiazol-5-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene (5.4 g) in N,N-dimethylformamide (100 cc). The mixture is stirred for 1 hour at 5° C., the temperature is then allowed to rise and the mixture is stirred for 4 hours at 23° C. Acetic acid (0.5 cc) is added, the mixture is stirred for 5 minutes and the suspension is filtered. The filtrate is poured into a 50/50 (by volume) mixture of water and ethyl acetate (500 cc). The organic phase is decanted and then washed successively with a 0.1 N solution of hydrochloric acid (100 cc), a saturated solution of sodium bicarbonate (100 cc), distilled water (100 cc) and a saturated solution of sodium chloride (100 cc). It is dried over anhydrous sodium sulphate and filtered and the filtrate is concentrated to dryness under reduced pressure (20 mm Hg; 2.7 kPa) at 30° C. The residue is purified by chromatography on silica gel (0.05-0.2 mm) (height of silica: 77 cm, diameter of the column: 3.5 cm), elution being carried out with a 20/80 (by volume) mixture of cyclohexane and ethyl acetate (1 liter) and then with a 10/90 (by volume) mixture of cyclohexane and ethyl acetate (3.8 liters) and 60 cc fractions being collected. Fractions 39 to 80 are combined and concentrated to dryness under reduced pressure (20 mm Hg; 2.7 kPa). This gives the syn isomer of 2-benzhydryloxycarbonyl-7-[2-methoxyimino-2-(2-tritylaminothiazol-4-yl)-acetamido]-8-oxo-3-[2-(pyridin-3-yl-methyl)thiazol-5-yl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene (5.43 g) in the form of a hard yellow foam.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04508717 |
|---|
| Source dataset | uspto-grants-1985_04 |
|---|
| ORD ID | ord-212c2ab462d64cc287c7c4c31f453572 |
|---|
| Source note | uspto-grants-1985_04 |
|---|